Abstract 10228: ABSORB Cohort B Trial: Two Year OCT Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold

Robert‐Jan van Geuns; Patrick W. Serruys; John Ormiston

Related publications

Article2011

Abstract 10228: ABSORB Cohort B Trial: Two Year OCT Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold

Robert‐Jan van Geuns, Patrick W. Serruys, John Ormiston

Article2010

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston, Bernard De Bruyne, Evelyn Regar, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel‐Hébert, Richard Rapoza, Héctor M. García‐García

Circulation

Article2014

OCT Assessment of the Long-Term Vascular Healing Response 5 Years After Everolimus-Eluting Bioresorbable Vascular Scaffold

Αντώνιος Καρανάσος, Cihan Şimşek, Muthukarrupan Gnanadesigan, Nienke S. van Ditzhuijzen, Raphael Freire, Jouke Dijkstra, Shengxian Tu, Nicolas M. Van Mieghem, Gijs van Soest, Peter de Jaegere, Patrick W. Serruys, Felix Zijlstra, Robert‐Jan van Geuns, Evelyn Regar

Journal of the American College of Cardiology

Article2012

First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold

John A. Ormiston, Patrick W. Serruys, Yoshinobu Onuma, Robert‐Jan van Geuns, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Richard Rapoza, Héctor M. García‐García

Circulation Cardiovascular Interventions

Article2014

Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffold

Yao‐Jun Zhang, Javaid Iqbal, Shimpei Nakatani, Christos V. Bourantas, Carlos M. Campos, Yuki Ishibashi, Yun‐Kyeong Cho, Susan Veldhof, Jin Wang, Yoshinobu Onuma, Héctor M. García‐García, Dariusz Dudek, Robert‐Jan van Geuns, Patrick W. Serruys

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Abstract 10228: ABSORB Cohort B Trial: Two Year OCT Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold

Abstract

Discussion(0)

Related publications

Abstract 10228: ABSORB Cohort B Trial: Two Year OCT Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

OCT Assessment of the Long-Term Vascular Healing Response 5 Years After Everolimus-Eluting Bioresorbable Vascular Scaffold

First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold

Scaffold and Edge Vascular Response Following Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffold